NDC 50480-010 - Keto-Plex Forte
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50480-010
- Package NDCs from labels
- 50480-010-99
- Manufacturer
- Radix Laboratories, Inc.
- Effective date
- 2014-12-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| KETO-PLEX FORTE | Radix Laboratories, Inc. | 2014-12-22 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50480-010-99 | Keto-Plex Forte | 12 in 1 CARTON | LIQUID | 12 | 3 | |
| 50480-010-99 | Keto-Plex Forte | 1000 mL in 1 BOTTLE, PLASTIC | LIQUID | 1000 | 3 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| AMINO ACIDS | ACTIVE INGREDIENT | 0O72R8RF8A | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| CALCIUM CHLORIDE | ACTIVE INGREDIENT | M4I0D6VV5M | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| DEXTROSE MONOHYDRATE | ACTIVE INGREDIENT | LX22YL083G | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CHLORIDE | ACTIVE INGREDIENT | 02F3473H9O | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| AMINO ACIDS | ACTIVE MOIETY | 0O72R8RF8A | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| ANHYDROUS DEXTROSE | ACTIVE MOIETY | 5SL0G7R0OK | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | KETO-PLEX FORTE LIQUID [RADIX LABORATORIES, INC.] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 25% Dextrose Infant | 25% DEXTROSE INFANT | HF Acquisition Co. LLC, DBA Health First | 73d04839-a2bb-65dd-e053-2991aa0a82ca | 2022-12-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Company | 9c80dfee-8923-4d1f-85b0-98bd68b94212 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 50603082-bce5-49eb-9737-e04239cfb695 | 2022-12-07 | Warnings, Adverse reactions | LX22YL083G |
| Multiple Electrolytes pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | 84221110-b3f1-42f4-800c-ad1d3b330e9e | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O |
| Multiple Electrolytes pH 5.5 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | Fresenius Kabi USA, LLC | cf1f5f15-d31d-4a02-8f7e-b289d5ad4b5c | 2022-11-10 | Warnings, Adverse reactions | 02F3473H9O |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) SOLUTION | Fenwal, Inc. | d55cb701-9664-4931-8754-1a8cae68da06 | 2022-11-01 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE (CPDA-1) SOLUTION | Fenwal, Inc. | f9d7f1b4-7a77-44f9-8924-10b16008b49d | 2022-11-01 | LX22YL083G | |
| Anticoagulant Citrate Phosphate Dextrose (CPD) Blood-Pack Units in PL 146 Plastic | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE (CPD) | Fenwal, Inc. | 4a08a9ec-46a5-4fcf-80ee-5c33f1a8b746 | 2022-11-01 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 66713d9c-f404-4ec8-e053-2a91aa0a620a | 2022-10-13 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | 677bb6d6-704b-5be5-e053-2991aa0a5f6f | 2022-10-13 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | Medical Purchasing Solutions, LLC | dc6664a6-1be1-676c-e053-2995a90a3490 | 2022-10-07 | Warnings, Adverse reactions | LX22YL083G |
| Magnesia Muriatica | MAGNESIA MURIATICA | Hahnemann Laboratories, INC. | e45cf05f-7ca8-2654-e053-2a95a90a7425 | 2022-07-21 | 02F3473H9O | |
| Cardioplegic Solution | POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE | Fresenius Kabi, USA, LLC | eb360dc4-88d6-4b28-9b61-bc359e16bd22 | 2022-05-27 | Warnings, Adverse reactions | 02F3473H9O M4I0D6VV5M |
| Calcarea Muriatica | CALCAREA MURIATICA | Hahnemann Laboratories, INC. | df517477-164b-33cc-e053-2a95a90a2083 | 2022-05-18 | M4I0D6VV5M | |
| ACD Blood-Pack Units (PL 146 PLASTIC) | ANTICOAGULANT CITRATE DEXTROSE (ACD) | Fenwal, Inc. | ba894daa-688e-4a9e-bd74-e71797f951bb | 2022-04-27 | LX22YL083G | |
| ACD-A | ANTICOAGULANT CITRATE DEXTROSE SOLUTION FORMULA A | Fenwal, Inc. | 22805f0d-ba58-41ea-b245-19980abcda22 | 2022-02-11 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | d763511e-f1a7-4014-94b9-f7ad8f023ff4 | 2021-12-02 | LX22YL083G | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | cf9f43a0-c750-4cf0-ac49-176ab2105aab | 2021-12-02 | LX22YL083G | |
| CONSTIPATION CP | ALUMINUM OXIDE, BRYONIA ALBA ROOT, MATRICARIA RECUTITA, GRAPHITE, LYCOPODIUM CLAVATUM SPORE, STRYCHNOS NUX-VOMICA SEED, SILICON DIOXIDE, SULFUR, SODIUM CHLORIDE, MAGNESIUM CHLORIDE, LEAD, SEPIA OFFICINALIS JUICE. | Natural Creations, Inc. | 961b3ddf-41fe-46ed-b5e4-0fd8d9652edf | 2021-11-15 | Warnings | 02F3473H9O |
| Magnesium Chloride | MAGNESIUM CHLORIDE | Mylan Institutional LLC | 2105d1c1-54ef-4d1a-a63c-b1619e8b50db | 2021-10-15 | Warnings, Adverse reactions | 02F3473H9O |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.